{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:44:02Z","timestamp":1773956642364,"version":"3.50.1"},"reference-count":35,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.eurpsy.2011.01.013","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T02:01:26Z","timestamp":1306029686000},"page":"426-431","source":"Crossref","is-referenced-by-count":38,"title":["Remission as perceived by people with schizophrenia, family members and psychiatrists"],"prefix":"10.1017","volume":"27","author":[{"given":"A.","family":"Karow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","reference":[{"key":"10.1016\/j.eurpsy.2011.01.013_bib0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00019053-200826020-00005","article-title":"The burden of schizophrenia on caregivers: a review","volume":"26","author":"Awad","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-1781(94)90075-2","article-title":"Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale","volume":"52","author":"Bell","year":"1994","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00406-005-0588-4","article-title":"Psychological pathways to depression in schizophrenia: studies in acute psychosis, postpsychotic depression and auditory hallucinations","volume":"255","author":"Birchwood","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1076729","article-title":"Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia","volume":"41","author":"de Haan","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0035","first-page":"51","article-title":"Patient-based and clinician-based support for the remission criteria in schizophrenia","volume":"22","author":"Docherty","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4088\/JCP.v65n0709","article-title":"Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects","volume":"65","author":"Hofer","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-958520","article-title":"Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine","volume":"40","author":"Hofer","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0050","article-title":"Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder","author":"Hofer","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","article-title":"Quality of life in schizophrenia: contributions of anxiety and depression","volume":"51","author":"Huppert","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- versus first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2648.2004.03157.x","article-title":"Schizophrenia: problems of separation in families","volume":"47","author":"Jungbauer","year":"2004","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/oxfordjournals.schbul.a007114","article-title":"The disregarded caregivers: subjective burden in spouses of schizophrenia patients","volume":"30","author":"Jungbauer","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0883-9417(03)00056-6","article-title":"Subjective burden over 12\u00a0months in parents of patients with schizophrenia","volume":"17","author":"Jungbauer","year":"2003","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4088\/JCP.v68n0110","article-title":"Association of subjective well-being, symptoms, and side effects with compliance after 12\u00a0months of treatment in schizophrenia","volume":"68","author":"Karow","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000088921","article-title":"PANSS syndromes and quality of life in schizophrenia","volume":"38","author":"Karow","year":"2005","journal-title":"Psychopathology"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0090","article-title":"The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life","author":"Karow","year":"2007","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2006-931541","article-title":"What would the patient choose? Subjective comparison of atypical and typical neuroleptics","volume":"39","author":"Karow","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2009.03.004","article-title":"Subjective well-being under quetiapine treatment: effect of diagnosis, mood state, and anxiety","volume":"110","author":"Lambert","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2008.01213.x","article-title":"Rates and predictors of remission and recovery during three years in 392\u00a0never-treated patients with schizophrenia","volume":"118","author":"Lambert","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1234105","article-title":"Early- and delayed antipsychotic response and prediction of outcome in 528\u00a0severely impaired patients with schizophrenia treated with amisulpride","volume":"42","author":"Lambert","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0125","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","article-title":"Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960\u00a0patients with schizophrenia","volume":"67","author":"Lambert","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2009.04.029","article-title":"The \u201cFunctional Remission of General Schizophrenia\u201d (FROGS) scale: development and validation of a new questionnaire","volume":"113","author":"Llorca","year":"2009","journal-title":"Schizophr Res"},{"issue":"Suppl 3","key":"10.1016\/j.eurpsy.2011.01.013_bib0135","first-page":"133","article-title":"A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables","volume":"10","author":"Naber","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.eurpsy.2011.01.013_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0920-9964(00)00166-3","article-title":"Improvement of schizophrenic patients; subjective well-being under atypical antipsychotic drugs","volume":"50","author":"Naber","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0020764007084600","article-title":"What does recovery from schizophrenia mean? Perceptions of long-term patients","volume":"54","author":"Ng","year":"2008","journal-title":"Int J Soc Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0150","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1017\/S1461145709000352","article-title":"Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone versus haloperidol","volume":"12","author":"Potkin","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005053-200305000-00003","article-title":"Predicting changes in domain-specific quality of life of schizophrenia patients","volume":"191","author":"Ritsner","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.106.025353","article-title":"Burden on caregivers of people with schizophrenia: comparison between Germany and Britain","volume":"190","author":"Roick","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cap.2005.15.249","article-title":"Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics","volume":"15","author":"Schimmelmann","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2006.04.001","article-title":"The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions","volume":"85","author":"van der Gaag","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.eurpsy.2011.01.013_bib0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","volume":"113","author":"van Os","year":"2006","journal-title":"Acta Psychiatr Scand"}],"container-title":["European Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933811000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933811000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T22:40:59Z","timestamp":1578004859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924933811000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0924933811000460"],"URL":"https:\/\/doi.org\/10.1016\/j.eurpsy.2011.01.013","relation":{},"ISSN":["0924-9338"],"issn-type":[{"value":"0924-9338","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}